Investing.com - BIO-Key (NASDAQ: BKYI) reported third quarter EPS of $-0.080, $0.10 better than the analyst estimate of $-0.180. Revenue for the quarter came in at $1.83M versus the consensus estimate of $2.2M.
BIO-Key's stock price closed at $0.190. It is down -72.860% in the last 3 months and down -86.750% in the last 12 months.
BIO-Key saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See BIO-Key's stock price’s past reactions to earnings here.
According to InvestingPro, BIO-Key's Financial Health score is "weak performance".
Check out BIO-Key's recent earnings performance, and BIO-Key's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar